TABLE III. Different outcomes according to the medication used.
ETV [n/n (%)] | TDF [n/n (%)] | p | |
---|---|---|---|
HBV-DNA loss | 146/165 (88.5) | 240/288 (83.3) | 0.376 |
HBeAg loss | 19/24 (79) | 18/25 (72) | 0.508 |
Anti-HBe seroconvertion | 3/19 (15.8) | 1/18 (5.56) | 0.604 |
ALT normalisation | 36/72 (50) | 68/128 (53.1) | 0.671 |
ALT: alanine aminotransferase; anti-HBe: antibody to the e antigen; ETV: entecavir; HBeAg: hepatitis B e antigen; HBV: hepatitis B virus; TDF: tenofovir.